Diversify Advisory Services LLC Purchases New Shares in HealthEquity, Inc. $HQY

Diversify Advisory Services LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the second quarter, HoldingsChannel reports. The fund purchased 90,675 shares of the company’s stock, valued at approximately $8,981,000.

Several other hedge funds and other institutional investors have also bought and sold shares of HQY. Oxbow Advisors LLC bought a new position in shares of HealthEquity during the second quarter worth approximately $3,431,000. Summit Creek Advisors LLC bought a new stake in shares of HealthEquity in the second quarter valued at approximately $7,601,000. Citizens Financial Group Inc. RI bought a new stake in shares of HealthEquity in the second quarter valued at approximately $398,000. BlackRock Inc. acquired a new stake in HealthEquity during the second quarter worth approximately $1,018,621,000. Finally, Deutsche Bank AG acquired a new stake in HealthEquity during the second quarter worth approximately $11,986,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the subject of several analyst reports. Wells Fargo & Company set a $111.00 price objective on HealthEquity in a report on Monday, June 1st. Royal Bank Of Canada increased their target price on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a report on Wednesday, June 3rd. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Wall Street Zen downgraded HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $110.00 price objective on shares of HealthEquity in a research report on Friday, May 22nd. Eleven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HealthEquity has a consensus rating of “Moderate Buy” and a consensus target price of $110.93.

Insiders Place Their Bets

In related news, EVP Delano Ladd sold 7,500 shares of HealthEquity stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the sale, the executive vice president directly owned 91,141 shares of the company’s stock, valued at approximately $8,202,690. The trade was a 7.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This represents a 5.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 17,905 shares of company stock valued at $1,651,280. 1.60% of the stock is currently owned by corporate insiders.

HealthEquity Trading Up 0.4%

Shares of HQY opened at $102.79 on Wednesday. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $107.62. The business’s fifty day moving average is $95.71 and its 200-day moving average is $86.80. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The firm has a market cap of $8.59 billion, a price-to-earnings ratio of 38.50, a PEG ratio of 1.76 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.